- Home
- ONDS vs CPRX Comparison
ONDS vs CPRX Comparison
Compare ONDS & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- CPRX
- Stock Information
- Founded
- ONDS 2014
- CPRX 2002
- Country
- ONDS United States
- CPRX United States
- Employees
- ONDS N/A
- CPRX N/A
- Industry
- ONDS Telecommunications Equipment
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- ONDS Telecommunications
- CPRX Health Care
- Exchange
- ONDS Nasdaq
- CPRX Nasdaq
- Market Cap
- ONDS 2.2B
- CPRX 2.6B
- IPO Year
- ONDS N/A
- CPRX 2006
- Fundamental
- Price
- ONDS $6.68
- CPRX $21.00
- Analyst Decision
- ONDS Strong Buy
- CPRX Strong Buy
- Analyst Count
- ONDS 4
- CPRX 5
- Target Price
- ONDS $7.25
- CPRX $33.20
- AVG Volume (30 Days)
- ONDS 52.9M
- CPRX 1.3M
- Earning Date
- ONDS 11-13-2025
- CPRX 11-05-2025
- Dividend Yield
- ONDS N/A
- CPRX N/A
- EPS Growth
- ONDS N/A
- CPRX 183.96
- EPS
- ONDS N/A
- CPRX 1.65
- Revenue
- ONDS $16,131,404.00
- CPRX $558,499,000.00
- Revenue This Year
- ONDS $284.53
- CPRX $16.59
- Revenue Next Year
- ONDS $189.78
- CPRX $8.80
- P/E Ratio
- ONDS N/A
- CPRX $12.96
- Revenue Growth
- ONDS 75.16
- CPRX 28.55
- 52 Week Low
- ONDS $0.57
- CPRX $19.05
- 52 Week High
- ONDS $11.70
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- ONDS 41.81
- CPRX 53.46
- Support Level
- ONDS $6.66
- CPRX $20.66
- Resistance Level
- ONDS $8.32
- CPRX $21.52
- Average True Range (ATR)
- ONDS 0.96
- CPRX 0.54
- MACD
- ONDS -0.39
- CPRX 0.04
- Stochastic Oscillator
- ONDS 4.53
- CPRX 66.85
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).